Home > Financial Ratios > LYKA LABS

LYKA LABS
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for LYKA LABS
Please provide your vote to see the results

LYKA LABS Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 6.668.638.02-4.12-4.15

What is the latest Working Capital/Sales ratio of LYKA LABS ?

The latest Working Capital/Sales ratio of LYKA LABS is 6.66 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20256.66
Mar20248.63
Mar20238.02
Mar2022-4.12
Mar2021-4.15

How is Working Capital/Sales of LYKA LABS Trending?

Years Working Capital/Sales % Change
Mar2025 6.66
-22.83
Mar2024 8.63
7.61
Mar2023 8.02
Positive
Mar2022 -4.12
Negative
Mar2021 -4.15 -

Other Financial Ratios of LYKA LABS


Compare Working Capital/Sales ratio of peers of LYKA LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LYKA LABS ₹338.2 Cr 0.5% -3% -34.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,626.0 Cr 1.2% 4.4% -9.7% Stock Analytics
DIVIS LABORATORIES ₹180,669.0 Cr 5.8% 19.2% 16.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,793.0 Cr 1.4% 1.8% 10.8% Stock Analytics
CIPLA ₹122,103.0 Cr -3.7% -0.2% 1.6% Stock Analytics
DR REDDYS LABORATORIES ₹99,857.4 Cr -7.3% -4% -6.1% Stock Analytics


LYKA LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LYKA LABS

0.5%

-3%

-34.4%

SENSEX

-0.9%

4.6%

5%


You may also like the below Video Courses